A Democratic plan to slap tax penalties on companies with too many low paid workers would drive larger firms to outsource more of their labor unless Senate Finance Chairman Ron Wyden can plug potential holes in his plan, economists warned.

Johnson & Johnson’s single-shot coronavirus vaccine won the backing of a panel of U.S. government advisers, paving the way for authorization of the country’s third immunization against the deadly virus.

The U.S. Supreme Court said a California county must let five churches hold indoor services, adding to a line of orders that have curbed the power of government officials as they battle the spread of the coronavirus.

California will hold its two-day bar exam remotely in late July, becoming the most recent state to change test-taking procedures as the coronavirus pandemic stretches on.

A U.S. Supreme Court case over Illumina Inc.’s fetal DNA test patents gives the justices a chance to solidify a road map for how biotech companies can protect their diagnostic inventions.

A pair of self-described conservative lawyers are leading the fight to shut down the U.S. election conspiracy theory, pitting themselves against some of the loudest voices on the right.

Owners want their brand everywhere, but Peloton Interactive Inc.'s bid to cancel “spinning” trademarks reminds companies they must manage threats of a certain kind of pervasiveness—a mark that ends up defining a product, not its producer.